GPX Medical in Media

We develop technology for improving the care and life quality of our most vulnerable patients – preterm born infants.

GPX Medical publicerar Bokslutskommuniké 2020

Pressmeddelande 16 februari 2021 GPX Medical publicerar idag Bokslutskommuniké för år 2020. Läs pressmeddelandet och rapporten i sin helhet här: Bokslutskommuniké 2020 Aktieägare och intressenter är varmt välkomna till bolagets rapportpresentation den 16 februari...

GPX Medical genomför bolagspresentation på Swiss Nordic Bio 2021

GPX Medical AB (publ) kommer att genomföra en bolagspresentation under Swiss Nordic Bio, en samarbetspartner- och investerarkonferens för schweiziska och nordiska aktörer inom biotech- och läkemedelsindustrin. På konferensen kommer potentiella samarbetspartners och...

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in GPX Medical

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund

Organization number: 559069-9012